ALEXANDRIA, Va., Aug. 6 -- United States Patent no. 12,378,238, issued on Aug. 5, was assigned to Terns Pharmaceuticals Inc. (Foster City, Calif.).

"Compounds as GLP-1R agonists" was invented by Corey Reeves (Foster City, Calif.), F. Anthony Romero (Redwood City, Calif.), Christopher T. Jones (Foster City, Calif.) and Martijn Fenaux (San Mateo, Calif.).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present application provides compounds that may be used as a glucagon-like peptide-1 receptors (GLP-1R) agonist, or pharmaceutically acceptable salts thereof. Also provided are pharmaceutical compositions containing such compounds, or pharmaceutically acceptable salts thereof. Methods of preparing these compoun...